Dynavax Technologies Corporation news

   Watch this stock
Showing stories 11 - 20 of about 80   

Articles published

DVAX 29.22 -0.43 (-1.45%)
price chart
Will Dynavax Technologies Corporation (NASDAQ:DVAX) Surprise Analysts?
Dynavax Technologies Corporation (NASDAQ:DVAX) is next slated to report earnings for the current quarter on 2015-08-06. Brokerages covering the stock are currently expecting the firm to earn $-1.04 per share based on the 2 covering brokerages weighted ...
Dynavax Technologies: Positive Catalysts Right Around The Corner (DVAX)
Unfortunately, both the FDA and its European equivalent did not believe the sample size Dynavax used for the trials was big enough to grant approval for the vaccine.
Momentum Stock in Focus: Dynavax Technologies Corporation (NASDAQ:DVAX)
Dynavax Technologies Corporation (NASDAQ:DVAX) has been given a top momentum style rating by Zacks Research. This rating is an indicator of when a stock might be favorable to enter a position to take advantage of the equity movement in either an ...
Analyst Price Target Update on Dynavax Technologies Corporation  News Watch International
Zacks: Analysts Give Consensus Recommendation of "Strong Buy" to ...  sleekmoney
Dynavax Technologies Corporation (NASDAQ:DVAX) Brokerage Rating Update
Dynavax Technologies Corporation (NASDAQ:DVAX) has been handed a rating of 1 on a consensus basis by Zacks Research. Using a simplified 1 to 5 scale where 5 represents a Strong Sell and 1 a Strong Buy, 2 analysts polled by Zacks had their ratings ...
Stock Technical Report on Dynavax Technologies Corp (NASDAQ:DVAX)
Dynavax Technologies Corp (NASDAQ:DVAX) (TREND ANALYSIS) shares were traded with more than 50% increase in usual volume. The stock closed last trading session at $22, down by -1.57%, with a volume of 791,821 shares against an average volume ...
Dynavax Technologies Corporation Short Interest Update  OTC Outlook
Company Shares of Dynavax Technologies Corporation Rally 1.59%  American Trade Journal
The Shuman Law Firm Investigates Dynavax Technologies Corp.
BOULDER, Colo.--(BUSINESS WIRE)--The Shuman Law Firm announces that it is investigating potential claims against certain officers and directors of Dynavax Technologies Corp. (“Dynavax” or the “Company”) (Nasdaq: DVAX). Dynavax is a California ...
Looking Ahead in Biotech: Ariad Pharmaceuticals, Inc. (ARIA), Dynavax ...
Y Katherine Xu of William Blair offers insight into a handful of biotechnology companies scheduled to release data updates including Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Dynavax Technologies Corporation (NASDAQ:DVAX), and OncoGenex ...
Stock Update (NASDAQ:DVAX): Merck & Co., Inc. and Dynavax Technologies ...
Merck & Co., Inc. (NYSE:MRK), known as MSD outside the United States and Canada, and Dynavax Technologies Corporation (NASDAQ:DVAX) announced they have entered into two clinical trial collaboration agreements to investigate the potential ...
Merck and Dynavax Announce New Collaboration Investigating the Combination ...  MarketWatch
Merck And Dynavax Collaborate On Immuno-Oncology Therapies - Quick Facts  Nasdaq
Biotech Stocks Getting Lots of Love - Dynavax Technologies Corporation (NASDAQ ...
Dynavax Technologies Corporation (NASDAQ:DVAX) gained +6.32% to close last trading session at $28.11. The company, on July 09, 2015, announced that the independent Data and Safety Monitoring Board (DSMB) charged with periodically reviewing ...
Dynavax Technologies Corp (DVAX) is Trading Higher on Unusual Volume for June 30
Dynavax Technologies Corp (DVAX) experienced unusually high volume on Jun. 30, as the stock gained 6.48% to a closing price of $23.43.
Dynavax Technologies Corporation (NASDAQ:DVAX) Analyst Rating Update  American Trade Journal